To Evaluate the Therapeutic Equivalence and Safety in Treatment of Moderate Facial Rosacea

Completed · Phase 1 · Has a placebo group

Conditions studied: Rosacea

In brief

To demonstrate the superiority of the efficacy of the test and reference products over that of the placebo control in the treatment of moderate facial rosacea.

Key facts

Study ID

NCT03689010

Run by

Sun Pharmaceutical Industries, Inc.

People needed

1116

Starts

2017-12-12

Expected to finish

2018-09-28

Last updated by the study team

2019-03-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy male or non-pregnant female aged ≥ 18 with a clinical diagnosis of facial rosacea.
• Subjects must have provided IRB approved written informed consent.

You may not qualify if…

• Female Subjects who are pregnant, nursing or planning to become pregnant during study participation.
• Subjects who have used estrogens or oral contraceptives for less than 3 months prior to baseline; use of such therapy must remain constant throughout the study.

Where it is running

• Catawba Research, LLC — Charlotte, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.